Global Deep Brain Stimulation Devices Strategic Business Report 2018: Market Dynamics, Targeted Indications, Product Overview, Recent Industry Activity & Focus on Select Players

Dublin, March 27, 2018 -- The "Deep Brain Stimulation Devices - Global Strategic Business Report" report has been added to ResearchAndMarkets.com's offering.

The report provides separate comprehensive analytics for the US, Canada, Japan, Europe, Asia-Pacific, Latin America, and Rest of World. Annual estimates and forecasts are provided for the period 2016 through 2024. Also, a five-year historic analysis is provided for these markets. Market data and analytics are derived from primary and secondary research. This report analyzes the worldwide markets for Deep Brain Stimulation Devices in US$ Thousand.

The report profiles 21 companies including many key and niche players such as:

• Abbott Laboratories (USA)
• Aleva Neurotherapeutics SA (Switzerland)
• Boston Scientific Corp. (USA)
• Deep Brain Innovations, LLC (USA)
• Medtronic Plc. (Ireland)
• Beijing Pins Medical Co., Ltd. (China)
• SceneRay Corporation Limited (China)
  

Key Topics Covered:

1. INDUSTRY OVERVIEW

A Prelude
Introduction to Deep Brain Stimulation Devices
Deep Brain Stimulation
Then and Now
Global Market Overview
Competitive Landscape
Select Available Deep Brain Stimulation Devices Available in the Market
Recent Advancements and the Way Ahead

2. MARKET DYNAMICS

DBS Market Driven by the Minimally Invasive Treatment Conferred
Hybrid DBS Devices Witness Increased Demand
Aging Population and Rising Disease Prevalence: The Cornerstone for DBS
Rising Healthcare Expenditure Induces Momentum in the Market
Novel Applications Bode Tremendous Prospects
Technical Advancements Aid in Progress of DBS
Still Questions Arise on the Current Pace of Innovation
Closed-Loop Functionality Gaining Favor over Open-Loop in Neurostimulation
Investigational DBS Device Inches towards Closed-Loop Functionality
Promising Targets for PIGD
Steering Brain Stimulation
An Emerging Concept in DBS
Novel Leads Target Selective and Fractional Stimulation
Researchers Devise Temporal Interference Method for Non- Invasive Deep Brain Stimulation
Researchers Develop New Pulse Pattern to Improve DBS for Parkinson's
Researchers Eye Deep Brain Stimulation to Treat Depression
Role of DBS in Managing Movement Disorders among Children
Novel Electrode Configurations Aid in Localization and Side Effect Reduction
Nanotechnology
The Future of DBS Electrodes
On-Demand Stimulators Promise to Contribute to Superior Therapeutic Outcomes
Sophisticated Neurostimulators
Advances in Programming Promise Ease of Treatment
Visual Depiction of Electrical Field Comes to the Aid of Programming
Device Programmability Gains Precedence in Device Choice
Brain Imaging
Gaining Prominence in DBS
Novel Imaging Techniques Come to the Fore
New DBS Technique Promises Superior Outcomes
Lack of Large Scale Study Results Subdue Asleep DBS; for Now

3. TARGETED INDICATIONS FOR DBS

Parkinson's Disease
The Largest Application Market for DBS
The DBS Procedure for Parkinson's
Limitations of DBS
A Note on Incidence and Prevalence of Parkinson's Disease
Research Suggests Greater Benefits of DBS in Parkinson's
Innovations in DBS to Redefine Future of Parkinson's Treatment
Innovations Upgrading Current Devices
Novel Stimulation Patterns and Parameters
Innovation in Enhanced Stimulation
Researchers Develop New Pulse Pattern to Improve DBS for Parkinson's
A Highly Effective Therapy for Essential Tremor
Incidence and Prevalence of Essential Tremor
DBS in Dystonia
Clinical Evidence of DBS in Dystonia: An Overview of Results from Select Clinical Studies and Meta-Analyses
Dystonia Patient Selection Criteria for DBS
DBS in OCD
DBS in Epilepsy Treatment
Disease Overview
DBS in Tourette Syndrome
Research Progress So Far
Clinical Evidence of DBS in Tourette Syndrome: An Overview of Results from Select Clinical Studies and Meta-Analyses
Paucity of Effective Drugs Drives Shift in Psychiatric Disorder Treatment
Multiple Possible Targets Marr Progress of DBS in Depression Treatment
Overview of Select Studies on DBS in Depression Treatment
SCC
A Promising Target for Stimulation in Depression
Eating Disorders
A Note on Potential of DBS
DBS: A Potential Procedure to Treat Obesity
Anorexia Treatment
Where Does DBS Stand?
DBS in Dementia Treatment
Animal Studies Bode Well for Efficacy in Humans
Prospects of DBS in Chronic Pain Management

4. PRODUCT OVERVIEW

Deep Brain Stimulation
An Overview
A Brief Note on Birth and Evolution of DBS
Devices in Deep Brain Stimulation
Components of DBS System
Implantable Pulse Generator (IPG)
The Extension
Leads/Electrodes
Other Products used in DBS Procedures
Programmers
Accessories
DBS Procedure
A Brief Overview
DBS Placement and Calibration
Common Lead Targets for Select Neurological and Psychiatric Conditions in DBS
A Peek into Indications of DBS and Other Uses
DBS Complications
A Gist of Common Complications Associated with DBS

5. RECENT INDUSTRY ACTIVITY

Boston Scientific Earns CE Mark for Vercise Gevia DBS System
Medtronic SureTune(TM)3 Receives CE Mark for DBS Therapy
Medtronic SureTune(TM)3 Earns Health Canada Licence for DBS
Aleva Neurotherapeutics Plans to Obtain CE Mark for directSTIM Directional DBS System
St. Jude Medical Announces US FDA Approval & First Implant of DBS and Directional Lead
Medtronic's StealthStation Cranial Software gets FDA Clearance
Medtronic SureTune2(TM) Secures CE Mark for DBS Therapy
St Jude Medical Introduces the Infinity DBS System and Directional Lead
Medtronic DBS Therapy Receives FDA Approval
Abbott Takes Over St. Jude Medical
Aleva Neurotherapeutics Inks Strategic Partnership with Greatbatch
Medtronic Deep Brain Stimulation Receives FDA Approval
FDA Approves Activa Portfolio of DBS Neurostimulators for Full-Body MRI
Boston Scientific Receives CE Mark for Vercise DBS System for Treating Tremor
St. Jude Medical Secures US FDA Approval for Brio Neurostimulation System
Medtronic Obtains EU Clearance for Full-Body MR Conditional DBS Systems

6. FOCUS ON SELECT PLAYERS

7. GLOBAL MARKET PERSPECTIVE

Total Companies Profiled: 21 (including Divisions/Subsidiaries 22)

• The United States (11)
• Canada (1)
• Europe (7)
  • France (1)
  • Germany (3)
  • The United Kingdom (1)
  • Rest of Europe (2)
• Asia-Pacific (Excluding Japan) (3)
  

For more information about this report visit https://www.researchandmarkets.com/research/7j3c3k/global_deep_brain?w=12

CONTACT: ResearchAndMarkets.com
         Laura Wood, Senior Manager
         [email protected]
         For E.S.T Office Hours Call 1-917-300-0470
         For U.S./CAN Toll Free Call 1-800-526-8630
         For GMT Office Hours Call +353-1-416-8900
         Related Topics: Neurology Devices